Controlling Pharmaceutical Risks
Science, Cancer, and the Geneticization of Drug Testing
|Series title:||Genetics and Society Ser.|
|Publication Date:||Dec 2016|
| Book Format:||Hardback|
|List Price:||USD $145.00|
| Book Description: |
Controlling Pharmaceutical Risksis a case study of changes in drug testing since the late 1990s, specifically geneticization of carcinogenic risk assessment and regulation of pharmaceuticals. Radically new ways of determining whether medical drugs might cause cancer have been established world-wide since the turn of the century. At the heart of these transformations is the geneticization of drug testing and explanations for cancer induction. The most dramatic change in toxicology...